Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)

被引：0
|
作者：
Kadowaki, Takashi
Haneda, Masakazu
Inagaki, Nobuya
Taniguchi, Atsushi
Sakamoto, Masashi
Koiwai, Kazuki
Rattunde, Henning
Woerle, Hans J.
Broedl, Uli C.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1144-P
引用
收藏
页码：A297 / A298
页数：2
相关论文
共 50 条
  • [1] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    [J]. DIABETES, 2013, 62 : A282 - A282
  • [2] Empagliflozin Monotherapy Improves Glucose Control in Drug-Naive Patients With Type 2 Diabetes (T2DM)
    Roden, Michael
    Weng, Jianping
    Eilbracht, Jens
    Delafont, Bruno
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A280 - A280
  • [3] Empagliflozin as Add-On to Metformin Plus Sulfonylurea (SU) for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A279 - A279
  • [4] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Kovacs, Christopher
    Seshiah, Veeraswamy
    Swallow, Ros
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A291 - A291
  • [5] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2014, 63 : A69 - A69
  • [6] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael W.
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [7] Empagliflozin improves blood pressure in patients with type 2 diabetes (T2DM) and hypertension
    Tikkanen, I.
    Narko, K.
    Zeller, C.
    Green, A.
    Salsali, A.
    Broedl, U. C.
    Woerle, H. J.
    [J]. DIABETOLOGIA, 2013, 56 : S377 - S377
  • [8] Linagliptin Monotherapy Improves Glycemic Control in Japanese Patients with 12DM over 12 Weeks
    Kawamori, Ryuzo
    Inagaki, Nobuya
    Araki, Elichi
    Watada, Hirotaka
    Hayashi, Naoyuki
    Horie, Yoshiharu
    Sarashina, Akiko
    Woerle, Hans-Juergen
    Dugi, Klaus
    [J]. DIABETES, 2010, 59 : A190 - A190
  • [9] Weekly GLP-1 Agonist Albiglutide Monotherapy Improves Glycemic Parameters in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
    Nino, Antonio
    Okuda, Inaha
    Wilson, Timothy H.
    Yue, Lin
    Nakajima, Hiromu
    Tsuboi, Maho
    Carr, Molly C.
    [J]. DIABETES, 2016, 65 : A266 - A266
  • [10] Empagliflozin as Add-On to Basal Insulin for 78 Weeks Improves Glycemic Control With Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM)
    Rosenstock, Julio
    Jelaska, Ante
    Wang, Fei
    Kim, Gabriel
    Broedl, Uli C.
    Woerle, Hans J.
    [J]. DIABETES, 2013, 62 : A285 - A285
12345